In vitro and in vivo analysis of the human cyp3a5 promoter

被引：0
|
作者：
Nem, D. [1 ]
Qiu, H. [1 ]
Nestler, S. [1 ]
Goedtel-Armbrust, U. [1 ]
Wojnowski, L. [1 ]
机构：
[1] Univ Med Mainz, Mainz, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2010年 / 381卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [41] Contribution of CYP3A5 to vinorelbine metabolism:: Inconsistencies between in vitro models.
    Topletz, A.
    Dennison, J. B.
    Hall, S. D.
    Renbarger, J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S53 - S53
  • [42] Comparative drug metabolism by CYP3A4 and CYP3A5
    Huang, WL
    Lin, YS
    Dai, Y
    Totah, RA
    Calamia, JC
    Thummel, KE
    DRUG METABOLISM REVIEWS, 2003, 35 : 187 - 187
  • [43] Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes
    Dennison, Jennifer B.
    Jones, David R.
    Renbarger, Jamie L.
    Hall, Stephen D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02): : 553 - 563
  • [44] Statin regulation of CYP3A4 and CYP3A5 expression
    Vieira Willrich, Maria Alice
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    PHARMACOGENOMICS, 2009, 10 (06) : 1017 - 1024
  • [45] Characterization of androgen-regulated expression of CYP3A5 in human prostate
    Moilanen, Anne-Mari
    Hakkola, Jukka
    Vaarala, Markku H.
    Kauppila, Saila
    Hirvikoski, Pasi
    Vuoristo, Jussi T.
    Edwards, Robert J.
    Paavonen, Timo K.
    CARCINOGENESIS, 2007, 28 (05) : 916 - 921
  • [46] Inherent sex-dependent regulation of human hepatic CYP3A5
    Thangavel, Chellappagounder
    Boopathi, Ettickan
    Shapiro, Bernard H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (04) : 988 - 1000
  • [47] Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians
    Gebeyehu, E.
    Engidawork, E.
    Bijnsdorp, A.
    Aminy, A.
    Diczfalusy, U.
    Aklillu, E.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (02): : 130 - 137
  • [48] Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians
    E Gebeyehu
    E Engidawork
    A Bijnsdorp
    A Aminy
    U Diczfalusy
    E Aklillu
    The Pharmacogenomics Journal, 2011, 11 : 130 - 137
  • [49] In vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance
    Skauby, Ragnhild Heier
    Bergan, Stein
    Andersen, Anders M.
    Vethe, Nils Tore
    Christensen, Hege
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 129 (06) : 427 - 436
  • [50] Use of CPT-11 as an in vitro phenotypic probe for CYP3A4/CYP3A5 activity.
    Ramirez, J
    Innocenti, F
    Rivory, LP
    Relling, MV
    Schuetz, EG
    Ratain, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P61 - P61
12345